1. From the Department of Neurology, School of Medicine, and the Institute of Molecular Medicine and Genetics, School of Graduate Studies (C.V.B.), Medical College of Georgia, Augusta, Ga; the Research and Affiliations Service Line (C.V.B.), Augusta Veterans Affairs Medical Center, Augusta, Ga; LCT BioPharma, Inc (A.V.V, D.F.E.), Providence, RI; and Diatranz NZ Ltd/Living Cell Technologies (S.J.M.S., M.G., R.B.E.), Auckland, New Zealand.